Consolidated Statements of Operations - USD ($)	3 Months Ended			9 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	[1]	Jul. 31, 2018	Jul. 31, 2017	[1]
Consolidated Statements of Operations
Revenues	$ 3,715,767	$ 3,331,898		$ 10,731,096	$ 10,371,235
Cost of expenses:
Cost of revenues	3,908,281	1,508,510		8,173,702	4,757,598
Research and development expenses	151,185	186,352		455,014	600,205
Selling, general, and administrative expenses	2,254,846	2,107,303		6,751,959	5,814,285
Total costs and expenses	6,314,312	3,802,165		15,380,675	11,172,088
Loss from operations	(2,598,545)	(470,267)		(4,649,579)	(800,853)
Interest expense - related party	78,300	41,400		214,100	122,850
Other loss	0	0		4,506	5,221
Loss before income taxes	(2,676,845)	(511,667)		(4,868,185)	(928,924)
Provision / (benefit) for income taxes	0	86,500		0	(208,890)
Net loss	$ (2,676,845)	$ (598,167)		$ (4,868,185)	$ (720,034)
Net loss per common share - basic	$ (0.35)	$ (0.08)		$ (0.63)	$ (0.09)
Net loss per common share - diluted	$ (0.35)	$ (0.08)		$ (0.63)	$ (0.09)
Weighted average number of common shares outstanding - basic	7,696,091	7,696,091		7,696,091	7,693,069
Weighted average number of common shares outstanding - diluted	7,696,091	7,696,091		7,696,091	7,693,069

[1] Certain July 31, 2017 balances have been restated from previously reported results. Please refer to Note 2 of the Company’s Annual Report on Form 10-K for the year ended October 31, 2017